Samorita Hospital (DHA:SAMORITA) Research & Development: BDT Mil (TTM As of . 20)


DHA:SAMORITA Samorita Hospital Ltd DHA:SAMORITA
18 GF Score
Price BDT73.50
! 1 Warning Sign
View Full Analysis

What is Samorita Hospital Research & Development?

Samorita Hospital DHA:SAMORITA 18 Research & Development is BDT Mil as of . 20. GuruFocus rates DHA:SAMORITA with a GF Score™ of 18/100. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Samorita Hospital's Research & Development for the six months ended in . 20 was BDT0.00 Mil. Samorita Hospital does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.

Samorita Hospital  (DHA:SAMORITA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Samorita Hospital Research & Development Related Terms

Samorita Hospital Research & Development Historical Data

* Premium members only.

The historical data trend for Samorita Hospital's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Samorita Hospital Research & Development Chart

Samorita Hospital Annual Data
Trend
Research & Development

Samorita Hospital Semi-Annual Data
Research & Development
DHA:SAMORITA
18GF Score
Samorita Hospital Ltd DHA:SAMORITA
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Samorita Hospital Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of BDT Mil mean?
Samorita Hospital (DHA:SAMORITA) has a Research & Development of BDT Mil as of . 20. Research and development expense is the total cost for research and development activities. View historical data on Samorita Hospital and its competitors.
Is Samorita Hospital's Research & Development too high?
Samorita Hospital's current Research & Development is BDT Mil. Overall, Samorita Hospital has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Samorita Hospital's Research & Development compare to SPIN and USNU?
Samorita Hospital's Research & Development of BDT Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Samorita Hospital and its competitors. Samorita Hospital's current Research & Development is BDT Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Samorita Hospital stock overvalued right now?
Samorita Hospital (DHA:SAMORITA) has a current Research & Development of BDT Mil. The current Research & Development is BDT Mil. Samorita Hospital's overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Samorita Hospital (DHA:SAMORITA), the current Research & Development is BDT Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Samorita Hospital Business Description

Address 89/1 Panthapath, Dhaka, BGD, 1215
Samorita Hospital Ltd provides general hospital services including all types of medical treatment along with diagnostic services in Bangladesh. It offers various clinical services in the areas of internal medicine, neurology, diabetes and endocrinology, nephrology, respiratory medicine, gastroenterology and other.
18GF Score

Get the complete analysis for DHA:SAMORITA

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT73.50
Price